- Previous Close
0.0533 - Open
0.0521 - Bid 0.0428 x --
- Ask 0.0540 x --
- Day's Range
0.0521 - 0.0533 - 52 Week Range
0.0250 - 0.3500 - Volume
10,226 - Avg. Volume
3,712 - Market Cap (intraday)
830,372 - Beta (5Y Monthly) 3.31
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3600 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Panacea Life Sciences Holdings, Inc., operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other hemp companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies under the PANA Health, PANA Beauty, PANA Pet, PANA Sport, PANA Pure, and PANA Life brand name. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
www.panacealife.com40
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PLSH
View MorePerformance Overview: PLSH
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PLSH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PLSH
View MoreValuation Measures
Market Cap
830.37k
Enterprise Value
22.95M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.17
Price/Book (mrq)
--
Enterprise Value/Revenue
5.54
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-277.51%
Return on Assets (ttm)
-18.47%
Return on Equity (ttm)
--
Revenue (ttm)
2.76M
Net Income Avi to Common (ttm)
-7.67M
Diluted EPS (ttm)
-0.3600
Balance Sheet and Cash Flow
Total Cash (mrq)
117.15k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-170.86k